##################################################################################
# Document Properties Section

SET DOCUMENT Name = "Neuroinflammation"
SET DOCUMENT Description = "BEL file created for Industrial Systems Biology lab course at B-IT UniBonn"
SET DOCUMENT Version = "1.0"
SET DOCUMENT Copyright = "Copyright (c) 2016, Sakthi. All Rights Reserved."
SET DOCUMENT Authors = "Sakthi"
SET DOCUMENT Licenses = "CC 3.0"
SET DOCUMENT ContactInfo = "sakthi23293@gmail.com"

##################################################################################
# Definitions Section


DEFINE NAMESPACE ADO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/ADO.belns"
DEFINE NAMESPACE AFFX AS URL "http://resource.belframework.org/belframework/20150611/namespace/affy-probeset-ids.belns"
DEFINE NAMESPACE BRCO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/BRCO.belns"
DEFINE NAMESPACE CHEBI AS URL "http://resource.belframework.org/belframework/20150611/namespace/chebi.belns"
DEFINE NAMESPACE CHEBIID AS URL "http://resource.belframework.org/belframework/20150611/namespace/chebi-ids.belns"
DEFINE NAMESPACE CHEMBL AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/chembl-names.belns"
DEFINE NAMESPACE CHEMBLID AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/chembl-ids.belns"
DEFINE NAMESPACE CTO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/CTO.belns"
DEFINE NAMESPACE DO AS URL "http://resource.belframework.org/belframework/20150611/namespace/disease-ontology.belns"
DEFINE NAMESPACE DOID AS URL "http://resource.belframework.org/belframework/20150611/namespace/disease-ontology-ids.belns"
DEFINE NAMESPACE EGID AS URL "http://resource.belframework.org/belframework/20150611/namespace/entrez-gene-ids.belns"
DEFINE NAMESPACE FlyBase AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Dmel.belns"
DEFINE NAMESPACE GOBP AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-biological-process.belns"
DEFINE NAMESPACE GOBPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-biological-process-ids.belns"
DEFINE NAMESPACE GOCC AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-cellular-component.belns"
DEFINE NAMESPACE GOCCID AS URL "http://resource.belframework.org/belframework/20150611/namespace/go-cellular-component-ids.belns"
DEFINE NAMESPACE HGNC AS URL "http://resource.belframework.org/belframework/20150611/namespace/hgnc-human-genes.belns"
DEFINE NAMESPACE LMSD AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/LMSD.belns"
DEFINE NAMESPACE MESHC AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-chemicals.belns"
DEFINE NAMESPACE MESHCID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-chemicals-ids.belns"
DEFINE NAMESPACE MESHCS AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures.belns"
DEFINE NAMESPACE MESHCSID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures-ids.belns"
DEFINE NAMESPACE MESHD AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases.belns"
DEFINE NAMESPACE MESHDID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases-ids.belns"
DEFINE NAMESPACE MESHPP AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-processes.belns"
DEFINE NAMESPACE MESHPPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/mesh-processes-ids.belns"
DEFINE NAMESPACE MGI AS URL "http://resource.belframework.org/belframework/20150611/namespace/mgi-mouse-genes.belns"
DEFINE NAMESPACE NIFT AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/NIFT.belns"
DEFINE NAMESPACE NTN AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/Nutrition.belns"
DEFINE NAMESPACE PDO AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/PDO.belns"
DEFINE NAMESPACE PH AS URL "http://belief-demo.scai.fraunhofer.de/openbel/repository/namespaces/Placeholder.belns"
DEFINE NAMESPACE PMIBP AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmibp.belns"
DEFINE NAMESPACE PMICHEM AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmichem.belns"
DEFINE NAMESPACE PMICOMP AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmicomp.belns"
DEFINE NAMESPACE PMIDIS AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmidis.belns"
DEFINE NAMESPACE PMIPFAM AS URL "http://belief-demo.scai.fraunhofer.de/BeliefDashboard/dicten/namespaces/pmipfam.belns"
DEFINE NAMESPACE PTS AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/PTS.belns"
DEFINE NAMESPACE RGD AS URL "http://resource.belframework.org/belframework/20150611/namespace/rgd-rat-genes.belns"
DEFINE NAMESPACE SCHEM AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-chemicals.belns"
DEFINE NAMESPACE SCOMP AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-named-complexes.belns"
DEFINE NAMESPACE SDIS AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-diseases.belns"
DEFINE NAMESPACE SFAM AS URL "http://resource.belframework.org/belframework/20150611/namespace/selventa-protein-families.belns"
DEFINE NAMESPACE SP AS URL "http://resource.belframework.org/belframework/20150611/namespace/swissprot.belns"
DEFINE NAMESPACE SPID AS URL "http://resource.belframework.org/belframework/20150611/namespace/swissprot-ids.belns"
DEFINE NAMESPACE dbSNP AS URL "http://belief.scai.fraunhofer.de/openbel/repository/namespaces/SNP.belns"

DEFINE ANNOTATION Anatomy AS URL "http://resource.belframework.org/belframework/20131211/annotation/anatomy.belanno"
DEFINE ANNOTATION BodyRegion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-body-region.belanno"
DEFINE ANNOTATION CardiovascularSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-cardiovascular-system.belanno"
DEFINE ANNOTATION Cell AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell.belanno"
DEFINE ANNOTATION CellLine AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell-line.belanno"
DEFINE ANNOTATION CellStructure AS URL "http://resource.belframework.org/belframework/20131211/annotation/cell-structure.belanno"
DEFINE ANNOTATION DigestiveSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-digestive-system.belanno"
DEFINE ANNOTATION Disease AS URL "http://resource.belframework.org/belframework/20131211/annotation/disease.belanno"
DEFINE ANNOTATION FluidAndSecretion AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-fluid-and-secretion.belanno"
DEFINE ANNOTATION HemicAndImmuneSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-hemic-and-immune-system.belanno"
DEFINE ANNOTATION IntegumentarySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-integumentary-system.belanno"
DEFINE ANNOTATION MeSHAnatomy AS URL "http://resource.belframework.org/belframework/20131211/annotation/mesh-anatomy.belanno"
DEFINE ANNOTATION MeSHDisease AS URL "http://resource.belframework.org/belframework/20131211/annotation/mesh-diseases.belanno"
DEFINE ANNOTATION NervousSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-nervous-system.belanno"
DEFINE ANNOTATION RespiratorySystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-respiratory-system.belanno"
DEFINE ANNOTATION Species AS URL "http://resource.belframework.org/belframework/20131211/annotation/species-taxonomy-id.belanno"
DEFINE ANNOTATION Tissue AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-tissue.belanno"
DEFINE ANNOTATION UrogenitalSystem AS URL "http://resource.belframework.org/belframework/1.0/annotation/mesh-urogenital-system.belanno"

##################################################################################
# Statements Section

SET STATEMENT_GROUP = "Group 1"

# Add statements below this comment

# Article 1

SET Citation = {"PubMed","J Neuroinflammation. 2015 May 14;12:93. doi: 10.1186/s12974-015-0320-x","25966683"}

SET Evidence = "Parkinson's disease (PD) is one of the most common causes of dementia and motor deficits in the elderly"

SET Species = "10090"

path(MESHD:"Parkinson Disease") association path(MESHD:Dementia)
path(MESHD:"Parkinson Disease") association bp(GOBP:"motor behavior")

SET Evidence = "PD is characterized by the abnormal accumulation of the synaptic protein alpha-synuclein (α-syn) and degeneration of 
dopaminergic neurons in substantia nigra, which leads to neurodegeneration and neuroinflammation"

SET NervousSystem = "Substantia Nigra"

p(MGI:Snca) association path(MESHD:"Parkinson Disease")
path(PDO:"Nigrostriatal_dopaminergic_loss") association path(MESHD:"Parkinson Disease")
path(MESHD:"Parkinson Disease") association bp(ADO:"neuronal_damage")
path(MESHD:"Parkinson Disease") association bp(ADO:neuroinflammation)

UNSET NervousSystem

SET Evidence = "Lenalidomide has shown protective effects in an animal model of amyotrophic lateral sclerosis, and its mechanism of action 
involves modulation of cytokine production and inhibition of NF-κB signaling"

a(CHEBI:lenalidomide) association path(MESHD:"Amyotrophic Lateral Sclerosis")
a(CHEBI:lenalidomide) -| bp(GOBP:"NF-kappaB signaling")
a(CHEBI:lenalidomide) association bp(GOBP:"cytokine production")

SET Evidence = "Lenalidomide reduced motor behavioral deficits and ameliorated dopaminergic fiber loss in the striatum.This protective 
action was accompanied by a reduction in microgliosis both in striatum and hippocampus."

SET NervousSystem = {"Neostriatum","Hippocampus"}

a(CHEBI:lenalidomide) decreases bp(GOBP:"motor behavior")
a(CHEBI:lenalidomide) decreases bp(PDO:"Nigrostriatal_dopaminergic_loss")
a(CHEBI:lenalidomide) decreases bp(MESHD:Gliosis)

UNSET NervousSystem

SET Evidence = "Central expression of pro-inflammatory cytokines was diminished in lenalidomide-treated transgenic animals, together with 
reduction in NF-κB activation."

a(CHEBI:lenalidomide) decreases bp(GOBP:"cytokine production")
a(CHEBI:lenalidomide) decreases bp(GOBP:"NF-kappaB signaling")

UNSET Species

# Article 2

SET Citation = {"PubMed","J Neuroinflammation. 2015 May 21;12:98. doi: 10.1186/s12974-015-0316-6","25990934"}

SET Evidence = "Expression levels of the chemokines CXCL1, CXCL2, and CXCL5 were significantly increased in the brain following the i.c.v. injection 
of LPS."

SET Species = "10090"

SET Anatomy = "brain"

a(CHEBI:lipopolysaccharide) increases r(MGI:Cxcl1)
a(CHEBI:lipopolysaccharide) increases r(MGI:Cxcl2)
a(CHEBI:lipopolysaccharide) increases r(MGI:Cxcl5)

UNSET Anatomy

SET Evidence = "In the CXCR2(-/-) and CXCL1(-/-) mice, the cerebral endothelial expression of adhesion molecules such as P-selectin and VCAM-1 was 
dramatically reduced."

p(MGI:Cxcr2) increases r(MGI:Vcam1)
p(MGI:Cxcl1) increases r(MGI:Vcam1)

SET Evidence = "Astrocyte culture conditioned medium significantly increased the expression of VCAM-1 and ICAM-1 in cerebral endothelial cells in a 
CXCR2-dependent manner. Additionally, CXCR2 messenger RNA (mRNA) expression in cerebral endothelial cells but not in microglia or astrocytes was 
increased following tumor necrosis factor-α (TNF-α) stimulation."

SET Cell = {"cerebral cortex endothelial cell","microglial cell","astrocyte"}

p(MGI:Cxcr2) increases r(MGI:Vcam1)
p(MGI:Cxcr2) increases r(MGI:Icam1)
r(MGI:Cxcr2) increases p(MGI:Tnf)

SET Evidence = "CXCL1 secreted by astrocytes and endothelial CXCR2 play essential roles in cerebral endothelial activation and subsequent leukocyte 
recruitment during neuroinflammation."

p(MGI:Cxcl1) association bp(ADO:neuroinflammation)
p(MGI:Cxcr2) association bp(ADO:neuroinflammation)
 
UNSET Species

UNSET Cell

# Article 3

SET Citation = {"PubMed","Neurochem Res. 2015 Jul;40(7):1497-508. doi: 10.1007/s11064-015-1624-z. Epub 2015 May 27","26012368"}
 
SET Evidence = "However, hyperactive microglia may release various cytotoxic factors and induce neuroinflammation, 
which cause neuronal damages leading to neurodegenerative diseases."

SET Species = "10090"

SET Cell = "microglial cell"

a("cytotoxic factors") increases bp(ADO:neuroinflammation)
bp(ADO:neuroinflammation) association path(MESHD:"Neurodegenerative Diseases")

UNSET Cell

UNSET Species

# Article 4

SET Citation = {"PubMed","Pain Med. 2015 Aug;16(8):1589-96. doi: 10.1111/pme.12733. Epub 2015 Jun 9","26058872"}

SET Evidence = "We propose that different CRPS subtypes may result from facilitative or inhibitory influences exerted by the 
spinal-coeruleo-spinal pathway in three sites at the spinal cord: the dorsal horn (DH), intermediolateral cell column (IML) and ventral horn (VH). 
A facilitatory influence over DH may have a pronociceptive effect that explains exacerbated pain, sensory disturbances, and 
spreading sensitization and neuroinflammation."

SET Species = "10090"

SET NervousSystem = "Spinal Cord"

path(MESHD:"Complex Regional Pain Syndromes") increases path(MESHD:Pain)
path(MESHD:"Complex Regional Pain Syndromes") increases bp("sensory disturbances")
path(MESHD:"Complex Regional Pain Syndromes") increases bp("sensitization")
path(MESHD:"Complex Regional Pain Syndromes") increases bp(ADO:neuroinflammation)

SET Evidence = "Conversely, a facilitatory influence over preganglionic neurons located in IML cell column may increase sympathetic outflow 
with peripheral vasoconstriction, which leads to cold skin, ipsilateral limb ischaemia, and sympathetically maintained pain (SMP)."

path(MESHD:"Complex Regional Pain Syndromes") increases bp("cold skin")
path(MESHD:"Complex Regional Pain Syndromes") increases path(MESHD:Ischemia)
path(MESHD:"Complex Regional Pain Syndromes") increases path(MESHD:Pain)

SET Evidence = "Finally, a descending inhibitory influence over VH could explain muscle weakness and decreased active range of motion, while 
also facilitating motor reflexes, tremor and dystonia."

path(MESHD:"Complex Regional Pain Syndromes") association bp(GOBP:"muscle atrophy")
path(MESHD:"Complex Regional Pain Syndromes") decreases bp(MESHPP:Movement) 
path(MESHD:"Complex Regional Pain Syndromes") increases bp(MESHPP:"Motor Activity")
path(MESHD:"Complex Regional Pain Syndromes") increases path(MESHD:Tremor)
path(MESHD:"Complex Regional Pain Syndromes") increases path(MESHD:Dystonia)

UNSET NervousSystem

UNSET Species

# Article 5

SET Citation = {"PubMed","J Cereb Blood Flow Metab. 2015 Nov;35(11):1804-11. doi: 10.1038/jcbfm.2015.128. Epub 2015 Jun 24","26104289"}

SET Evidence = "Dopamine is the predominant catecholamine in the brain and functions as a neurotransmitter."

SET Species = "10090"

SET Anatomy = "brain"

a(CHEBI:dopamine) isA a(CHEBI:catecholamine)
a(CHEBI:dopamine) isA a(CHEBI:neurotransmitter)

UNSET Anatomy 

SET Evidence = "However, cerebral ischemia induced the expression of D2R on Iba1-immunoreactive inflammatory cells in the infarct core and penumbra."

path(DO:"transient cerebral ischemia") increases r(MGI:Drd2)

SET Evidence = "Importantly, the D2/3R agonist, pramipexole, enhanced the secretion of nitrite by cultured microglia in response to proinflammatory
stimuli."

a(CHEBI:pramipexole) increases sec(a(CHEBI:nitrite))

SET Evidence = "Thus, dopamine may serve as a modulator of microglia function during neuroinflammation."

a(CHEBI:dopamine) association bp(ADO:neuroinflammation)

UNSET Species

# Article 6

SET Citation = {"PubMed","Discov Med. 2015 May;19(106):381-92","26105701"}

SET Evidence = "Sterile inflammation occurs in the injured brain after stroke, with damaged tissue exposing central nervous system (CNS)-derived antigen 
that could initiate potential autoimmune responses."

SET Species = "10090"

bp(ADO:neuroinflammation) association bp("autoimmune responses")

SET Evidence = "Stroke induced a significant increase in autoreactive CD4+ and CD8+ T cells, as well as autoreactive CD19+ B cells, as early as 4 days 
after stroke onset."

path(ADO:stroke) increases p(MGI:Cd4)
path(ADO:stroke) increases p(MGI:Cd8a)
path(ADO:stroke) increases p(MGI:Cd8b1)
path(ADO:stroke) increases p(MGI:Cd19)

SET Evidence = "Based on these observations, we hypothesize that stroke induces a secondary, complex, and dynamic autoimmune response to neuronal 
antigens with the potential to potentiate, or perhaps even ameliorate, long-term neuroinflammation."

path(ADO:stroke) increases bp(ADO:neuroinflammation)

UNSET Species

# Article 7

SET Citation = {"PubMed","J Neuroinflammation. 2015 Jul 4;12:130. doi: 10.1186/s12974-015-0348-y","26141738"}

SET Evidence = "Astrocytes, the most abundant cell population in mammal central nervous system (CNS), contribute to a variety of functions including 
homeostasis, metabolism, synapse formation, and myelin maintenance."

SET Species = "10090"

SET NervousSystem = "Central Nervous System"

a(BRCO:Astrocyte) increases bp(MESHPP:Homeostasis)
a(BRCO:Astrocyte) increases bp(GOBP:"metabolic process")
a(BRCO:Astrocyte) increases bp(GOBP:"synapse assembly")
a(BRCO:Astrocyte) increases bp(GOBP:"myelin maintenance")

UNSET NervousSystem

SET Evidence = "White matter (WM) reactive astrocytes are important players in amplifying autoimmune demyelination and may exhibit different changes 
in transcriptome profiles and cell function in a disease-context dependent manner."

a(BRCO:Astrocyte) increases bp("autoimmune demyelination")

UNSET Species
 
# Article 8

SET Citation = {"PubMed","Brain Behav Immun. 2015 Nov;50:298-313. doi: 10.1016/j.bbi.2015.07.015. Epub 2015 Jul 16","26188187"}

SET Evidence = "Brain inflammation plays an important role in the pathophysiology of many psychiatric and neurological diseases."

SET Species = "10090"

bp(ADO:neuroinflammation) association path(MESHD:"Mental Disorders")
bp(ADO:neuroinflammation) association path(MESHD:"Neurologic Manifestations")

SET Evidence = "During brain inflammation, microglia cells are activated, producing neurotoxic molecules and neurotrophic factors 
depending on their pro-inflammatory M1 and anti-inflammatory M2 phenotypes."

path(MESHD:Inflammation) increases sec(a(CHEBI:neurotoxin))
path(MESHD:Inflammation) increases sec(a("neurotrophic factors"))
#neurotrophins

UNSET Species

# Article 9

SET Citation = {"PubMed","Mol Immunol. 2015 Oct;67(2 Pt B):317-24. doi: 10.1016/j.molimm.2015.06.015. Epub 2015 Jul 19","26198700"}

SET Evidence = "Previously, we demonstrated Cdk5 to be an important regulator of T cell function and that disruption of Cdk5 expression
ameliorates T cell mediated neuroinflammation."
 
SET Species = "10116"

p(RGD:Cdk5) association act(a("T Cell"))
p(RGD:Cdk5) decreases bp(ADO:neuroinflammation)
 
SET Evidence = "Here, we show a novel role of Cdk5 in the regulation of Foxp3 expression in murine CD4(+) T cells."

SET Cell = "CD4-positive helper T cell"
 
p(RGD:Cdk5) association g(RGD:Foxp3)

UNSET Cell

SET Evidence = "Our data indicate that disruption of Cdk5 activity in T cells abrogates the IL-6 suppression of Foxp3 expression."

SET Cell = "T cell"
 
p(RGD:Cdk5) increases g(RGD:Il6)
g(RGD:Il6) association g(RGD:Foxp3)
 
SET Evidence = "This effect is achieved through Cdk5 phosphorylation of the signal transducer and activator of transcription 3 (Stat3) 
specifically at Serine 727 in T cells, and we show this post-translational modification is required for proper Stat3 DNA binding to the 
Foxp3 gene on the enhancer II region."

p(RGD:Cdk5,pmod(P)) association g(RGD:Foxp3)
g(RGD:Stat3) association g(RGD:Foxp3) 

UNSET Cell

UNSET Species

# Article 10

SET Citation = {"PubMed","J Immunol. 2015 Sep 1;195(5):2251-62. doi: 10.4049/jimmunol.1500370. Epub 2015 Jul 22","26202983"}

SET Evidence = "Japanese encephalitis virus (JEV) can target CNS and cause neuroinflammation that is characterized by profound neuronal damage 
and concomitant microgliosis/astrogliosis."

SET Species = "10090"

SET NervousSystem = "Central Nervous System"

a("Japanese encephalitis virus") association bp(ADO:neuroinflammation)
bp(ADO:"neuronal_damage") increases bp(ADO:neuroinflammation)
bp(MESHD:Gliosis) increases bp(ADO:neuroinflammation)

UNSET NervousSystem

SET Evidence = "In this study, we found that miR-15b is involved in modulating the JEV-induced inflammatory response. The data demonstrate that 
miR-15b is upregulated during JEV infection of glial cells and mouse brains.In vitro overexpression of miR-15b enhances the JEV-induced 
inflammatory response, whereas inhibition of miR-15b decreases it. "

m(MGI:Mir15b) increases path(MESHD:Inflammation)
path(MESHD:Infection) increases m(MGI:Mir15b)

SET Evidence = "Mechanistically, ring finger protein 125 (RNF125), a negative regulator of RIG-I signaling, is identified as a direct target of 
miR-15b in the context of JEV infection. Furthermore, inhibition of RNF125 by miR-15b results in an elevation in RIG-I levels, which, in turn, 
leads to a higher production of proinflammatory cytokines and type I IFN."

p(MGI:Rnf125) decreases bp(GOBP:"RIG-I signaling pathway")
p(MGI:Rnf125) association m(MGI:Mir15b)
m(MGI:Mir15b) -| p(MGI:Rnf125)
bp(GOBP:"RIG-I signaling pathway") increases bp(GOBP:"cytokine production")
bp(GOBP:"RIG-I signaling pathway") increases bp(GOBP:"type I interferon production")

SET Evidence = "In vivo knockdown of virus-induced miR-15b by antagomir-15b restores the expression of RNF125, reduces the production of 
inflammatory cytokines, attenuates glial activation and neuronal damage, decreases viral burden in the brain, and improves survival in the 
mouse model."

m(MGI:Mir15b) decreases p(MGI:Rnf125)
m(MGI:Mir15b) increases bp(GOBP:"cytokine production")
m(MGI:Mir15b) increases act(a(ADO:Microglial_activation))
m(MGI:Mir15b) increases bp(ADO:"neuronal_damage")
m(MGI:Mir15b) decreases bp(MESHPP:"Cell Survival")

SET Evidence = "Taken together, our results indicate that miR-15b modulates the inflammatory response during JEV infection by negative 
regulation of RNF125 expression."

m(MGI:Mir15b) increases path(MESHD:Inflammation)
m(MGI:Mir15b) negativeCorrelation p(MGI:Rnf125)

UNSET Species

# Article 11

SET Citation = {"PubMed","Mol Neurodegener. 2015 Jul 30;10:32. doi: 10.1186/s13024-015-0029-4","26223783"}

SET Evidence = "Parkinson's disease (PD) is a progressive neurodegenerative disorder that is pathologically characterized by loss of dopaminergic 
neurons from the substantia nigra, the presence of aggregated α-synuclein (αS) and evidence of neuroinflammation."

SET Species = "10090"

bp(PDO:"Nigrostriatal_dopaminergic_loss") association path(MESHD:"Parkinson Disease")
p(MGI:Snca) association path(MESHD:"Parkinson Disease")
bp(ADO:neuroinflammation) association path(MESHD:"Parkinson Disease")

SET Evidence = "As previously reported, injection of αS fibrils could induce astrogliosis, and αS inclusions were present within astrocytes in mice 
injected with fibrils comprised of αS with or without cation exchange purification."

a("αS fibrils") increases bp(MESHD:Gliosis)

UNSET Species

# Article 12

SET Citation = {"PubMed","J Neurovirol. 2016 Feb;22(1):66-79. doi: 10.1007/s13365-015-0369-4. Epub 2015 Aug 11","26260496"}

SET Evidence = "Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) is an important model of the progressive disability 
caused by irreversible CNS tissue injury, and provides an example of how a CNS pathogen can cause inflammation, demyelination, and neuronal damage."

SET Species = "10090"

path(MESHD:"Multiple Sclerosis") association path(MESHD:"Intellectual Disability")
path("CNS tissue injury") increases path(MESHD:"Multiple Sclerosis")
path(MESHD:"Multiple Sclerosis") increases path(MESHD:Inflammation)
path(MESHD:"Multiple Sclerosis") increases path(MESHD:"Demyelinating Diseases")
path(MESHD:"Multiple Sclerosis") increases bp(ADO:"neuronal_damage")

SET Evidence = "Protein detection in the CSF was broadly concordant with mRNA abundance of the corresponding gene measured by real-time RT-PCR in the 
spinal cord, since several cytokines/chemokines were increased in the CSF of TMEV-IDD mice."

SET NervousSystem = "Spinal Cord"

bp(GOBP:"cytokine production") increases r("mRNA")

UNSET NervousSystem

UNSET Species

# Article 13

SET Citation = {"PubMed","J Neuroinflammation. 2015 Aug 16;12:150. doi: 10.1186/s12974-015-0369-6","26275910"}

SET Evidence = "Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by neuronal loss due to amyloid beta aggregations, 
neurofibrillary tangles, and prominent neuroinflammation"

SET Species = "10090"

path(MESHD:"Alzheimer Disease") isA path(MESHD:"Neurodegenerative Diseases")
bp(ADO:"neuronal_damage") increases path(MESHD:"Alzheimer Disease")
p(ADO:"Abeta_42") increases path(MESHD:"Alzheimer Disease")
bp(ADO:"Neurofibrillary_tangle") increases path(MESHD:"Alzheimer Disease")
bp(ADO:neuroinflammation) increases path(MESHD:"Alzheimer Disease")

SET Evidence = "Late-stage immunization also showed a decrease in the number of activated microglia, and improved memory function, however, had no 
influence on the amyloid β load."

bp(ADO:"Immunization_statergies") decreases a("microglia")
bp(ADO:"Immunization_statergies") decreases path(ADO:"Memory_dysfunction")
bp(ADO:"Immunization_statergies") causesNoChange path(ADO:"amyloid_beta_deposition")

SET Evidence = "C5a-peptide vaccines represent a safe and well-tolerated immunotherapy, which is able to induce a strong and specific immune response 
against the pro-inflammatory molecule C5a. In a mouse model of AD, C5a-peptide vaccines reduce microglia activation and thus neuroinflammation, 
which is supposed to lead to reduced neuronal dysfunction and AD symptomatic decline."

p("C5a-peptide") decreases bp(ADO:neuroinflammation)
p("C5a-peptide") decreases bp(ADO:"neuronal_damage")
p("C5a-peptide") decreases path(MESHD:"Alzheimer Disease")

UNSET Species

# Article 14

SET Citation = {"PubMed","J Neurosci. 2015 Aug 19;35(33):11500-13. doi: 10.1523/JNEUROSCI.0343-15.2015","26290229"}

SET Evidence = "Alzheimer's disease (AD) is a frequent and irreversible age-related neurodegeneration without efficient treatment."

SET Species = "10090"

path(MESHD:"Alzheimer Disease") isA path(MESHD:"Neurodegenerative Diseases")

SET Evidence = "Experimental AD in mice responds positively to decreased insulin-like growth factor I (IGF-I) signaling, a pathway also implicated in 
aging."

bp(GOBP:"insulin-like growth factor receptor signaling pathway") decreases path(MESHD:"Alzheimer Disease")

SET Evidence = "We present for the first time evidence that IGF signaling has profound effects on neuronal proteostasis and maintenance of cell 
morphology in vivo." 

bp(GOBP:"insulin-like growth factor receptor signaling pathway") association bp(GOBP:"neuron cellular homeostasis")
bp(GOBP:"insulin-like growth factor receptor signaling pathway") association bp(MESHPP:"Cell Shape")
bp(GOBP:"insulin-like growth factor receptor signaling pathway") association bp(MESHPP:"Cell Size")

UNSET Species

# Article 15

SET Citation = {"PubMed","J Neuroinflammation. 2015 Aug 28;12:152. doi: 10.1186/s12974-015-0375-8","26310930"}

SET Evidence = "In brain inflammatory diseases, axonal damage is one of the most critical steps in the cascade that leads to permanent disability. 
Thus, identifying the initial events triggered by inflammation or oxidative stress that provoke axonal damage is critical for the development of 
neuroprotective therapies."

SET Species = "10090"

path(MESHD:"Diffuse Axonal Injury") association path(MESHD:"Intellectual Disability")
path(MESHD:Inflammation) increases path(MESHD:"Diffuse Axonal Injury")
bp(MESHPP:"Oxidative Stress") increases path(MESHD:"Diffuse Axonal Injury")

SET Evidence = "Energy depletion due to mitochondrial dysfunction has been postulated as an important step in the damage of axons."

path(MESHD:"Mitochondrial Diseases") association path(MESHD:"Diffuse Axonal Injury")

SET Evidence = "Such compensation was reflected at the tissue level as increased respiratory activity of complexes I and IV and as a transient 
increase in ATP production in response to acute inflammation."

path(MESHD:Inflammation) increases a(CHEBI:ATP)

SET Evidence = "Neuroinflammation acutely impairs axonal mitochondrial transportation, which would promote an inappropriate delivery of energy 
throughout axons and, by this way, contribute to axonal damage."

bp(ADO:neuroinflammation) decreases bp(GOBP:"axonal transport")
bp(ADO:neuroinflammation) association path(MESHD:"Diffuse Axonal Injury")

UNSET Species

# Article 16

SET Citation = {"PubMed","Neurobiol Aging. 2015 Nov;36(11):3008-19. doi: 10.1016/j.neurobiolaging.2015.08.003. Epub 2015 Aug 15","26362942"}

SET Evidence = "The modulation of endocannabinoid (EC) levels and the activation of cannabinoid receptors are seen as promising therapeutic 
strategies in a variety of diseases, including Alzheimer's disease (AD)"

SET Species = "10090"

act(p("MGI:Cnr1")) association path(MESHD:"Alzheimer Disease")
act(p("MGI:Cnr2")) association path(MESHD:"Alzheimer Disease")

SET Evidence = "CB1 blockade exacerbated inflammation in this transgenic mouse model of AD."

p("MGI:Cnr1") decreases path(MESHD:Inflammation)

SET Evidence = "The genetic inactivation of FAAH led to increases in the expression of inflammatory cytokines."

p(MGI:Faah) decreases a(SCHEM:cytokine)

SET Evidence = "Finally, mice lacking FAAH showed diminished soluble amyloid levels, neuritic plaques, and gliosis."

p(MGI:Faah) increases bp(MESHD:Gliosis)

UNSET Species

UNSET STATEMENT_GROUP

